Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Acquisition of CD13 and CD33 expression at relapse on acute myeloid leukemia cells with an unusual phenotype: MPO+CD13-CD33-.

Internal medicine (Tokyo, Japan) - 1 Sept 1993

Kawada H, Ichikawa Y, Kobayashi N, Fukuda R, Yonekura S, Nagao T

Abstract excerpt

A case of acute myeloid leukemia (AML) with an unusual phenotype which was negative for a panel of myeloid antigens determined by flow cytometry, but was strongly positive for myeloperoxidase has recently been reported. We herein describe a case of AML with this unusual phenotype at diagnosis; relapse occurred with the acquisition of CD13 and CD33 expressions. Morphological features of the blasts at relapse...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to Antigens, Differentiation, Myelomonocytic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cell Differentiation

Share to Leukemia, Myeloid, Acute

Share to Peroxidase

Share to Phenotype

Share to Recurrence

Share to Time Factors

Source

Identifiers

PMID: 7908235
DOI: 10.2169/internalmedicine.32.733

Genes

MPO

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Acquisition of CD13 and CD33 expression at relapse on acute myeloid leukemia cells with an unusual phenotype: MPO+CD13-CD33-.PMID 7908235Read ↗

Acute myeloid leukaemia with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-) and CD33 (-).Semantic proximity Read ↗

Acute promyelocytic leukemia: Immunophenotype and differential diagnosis by flow cytometrySemantic proximity Read ↗

Surface marker expression in acute myeloid leukaemia at first relapse.Semantic proximity Read ↗

Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML‐MO)Semantic proximity Read ↗

Flow cytometric analysis of CD64 expression pattern and density in the diagnosis of acute promyelocytic leukemia: a multi-center study in Shanghai, ChinaSemantic proximity Read ↗

Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPALisoMPO is distinct from other MPAL subtypes.Semantic proximity Read ↗

The diagnostic power of CD117, CD13, CD56, CD64, and MPO in rapid screening acute promyelocytic leukemiaSemantic proximity Read ↗

[CD13- and CD33-negative acute myelocytic leukemia (FAB classification; M2) with morphological changes and CD13 expression on recurrence].Semantic proximity Read ↗

Acute myeloblastic leukemia with minimal myeloid differentiation: phenotypical and ultrastructural characteristics.Semantic proximity Read ↗

Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemiaSemantic proximity Read ↗

Characterization of aberrant phenotypes in acute myeloblastic leukemia.Semantic proximity Read ↗

Acute myeloid leukemia M2 and t(8;21)(q22;q22) with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-), and CD33(-).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.